These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9700596)

  • 1. The effect of fasting, long-chain triglyceride load and carnitine load on plasma long-chain acylcarnitine levels in mitochondrial very long-chain acyl-CoA dehydrogenase deficiency.
    Costa CG; Dorland L; de Almeida IT; Jakobs C; Duran M; Poll-The BT
    J Inherit Metab Dis; 1998 Jun; 21(4):391-9. PubMed ID: 9700596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in blood carnitine and acylcarnitine profiles of very long-chain acyl-CoA dehydrogenase-deficient mice subjected to stress.
    Spiekerkoetter U; Tokunaga C; Wendel U; Mayatepek E; Exil V; Duran M; Wijburg FA; Wanders RJ; Strauss AW
    Eur J Clin Invest; 2004 Mar; 34(3):191-6. PubMed ID: 15025677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevations of C14:1 and C14:2 Plasma Acylcarnitines in Fasted Children: A Diagnostic Dilemma.
    Burrage LC; Miller MJ; Wong LJ; Kennedy AD; Sutton VR; Sun Q; Elsea SH; Graham BH
    J Pediatr; 2016 Feb; 169():208-13.e2. PubMed ID: 26602010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carnitine supplementation induces acylcarnitine production in tissues of very long-chain acyl-CoA dehydrogenase-deficient mice, without replenishing low free carnitine.
    Primassin S; Ter Veld F; Mayatepek E; Spiekerkoetter U
    Pediatr Res; 2008 Jun; 63(6):632-7. PubMed ID: 18317232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue carnitine homeostasis in very-long-chain acyl-CoA dehydrogenase-deficient mice.
    Spiekerkoetter U; Tokunaga C; Wendel U; Mayatepek E; Ijlst L; Vaz FM; van Vlies N; Overmars H; Duran M; Wijburg FA; Wanders RJ; Strauss AW
    Pediatr Res; 2005 Jun; 57(6):760-4. PubMed ID: 15774826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-exercise medium-chain triglyceride application prevents acylcarnitine accumulation in skeletal muscle from very-long-chain acyl-CoA-dehydrogenase-deficient mice.
    Primassin S; Tucci S; Herebian D; Seibt A; Hoffmann L; ter Veld F; Spiekerkoetter U
    J Inherit Metab Dis; 2010 Jun; 33(3):237-46. PubMed ID: 20446112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corresponding increase in long-chain acyl-CoA and acylcarnitine after exercise in muscle from VLCAD mice.
    ter Veld F; Primassin S; Hoffmann L; Mayatepek E; Spiekerkoetter U
    J Lipid Res; 2009 Aug; 50(8):1556-62. PubMed ID: 18980943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acylcarnitine profiles during carnitine loading and fasting tests in a Japanese patient with medium-chain acyl-CoA dehydrogenase deficiency.
    Yokoi K; Ito T; Maeda Y; Nakajima Y; Ueta A; Nomura T; Koyama N; Kato I; Suzuki S; Kurono Y; Sugiyama N; Togari H
    Tohoku J Exp Med; 2007 Dec; 213(4):351-9. PubMed ID: 18075239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carnitine supplementation attenuates myocardial lipid accumulation in long-chain acyl-CoA dehydrogenase knockout mice.
    Bakermans AJ; van Weeghel M; Denis S; Nicolay K; Prompers JJ; Houten SM
    J Inherit Metab Dis; 2013 Nov; 36(6):973-81. PubMed ID: 23563854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of plasma acylcarnitines using gas chromatography chemical ionization mass fragmentography.
    Costa CG; Struys EA; Bootsma A; ten Brink HJ; Dorland L; Tavares de Almeida I; Duran M; Jakobs C
    J Lipid Res; 1997 Jan; 38(1):173-82. PubMed ID: 9034211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A heterozygous missense mutation in adolescent-onset very long-chain acyl-CoA dehydrogenase deficiency with exercise-induced rhabdomyolysis.
    Hisahara S; Matsushita T; Furuyama H; Tajima G; Shigematsu Y; Imai T; Shimohama S
    Tohoku J Exp Med; 2015 Apr; 235(4):305-10. PubMed ID: 25843429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary excretion of l-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of l-carnitine.
    Chalmers RA; Roe CR; Stacey TE; Hoppel CL
    Pediatr Res; 1984 Dec; 18(12):1325-8. PubMed ID: 6441143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and therapeutic implications of medium-chain acylcarnitines in the medium-chain acyl-coA dehydrogenase deficiency.
    Roe CR; Millington DS; Maltby DA; Bohan TP; Kahler SG; Chalmers RA
    Pediatr Res; 1985 May; 19(5):459-66. PubMed ID: 4000772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal handling of carnitine in secondary carnitine deficiency disorders.
    Stanley CA; Berry GT; Bennett MJ; Willi SM; Treem WR; Hale DE
    Pediatr Res; 1993 Jul; 34(1):89-97. PubMed ID: 8356025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouse.
    Cox KB; Hamm DA; Millington DS; Matern D; Vockley J; Rinaldo P; Pinkert CA; Rhead WJ; Lindsey JR; Wood PA
    Hum Mol Genet; 2001 Sep; 10(19):2069-77. PubMed ID: 11590124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal screening for very long-chain acyl-coA dehydrogenase deficiency: enzymatic and molecular evaluation of neonates with elevated C14:1-carnitine levels.
    Liebig M; Schymik I; Mueller M; Wendel U; Mayatepek E; Ruiter J; Strauss AW; Wanders RJ; Spiekerkoetter U
    Pediatrics; 2006 Sep; 118(3):1065-9. PubMed ID: 16950999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of acylcarnitines from urine: a comparison of methods and application to long-chain acyl-CoA dehydrogenase deficiency.
    Morrow RJ; Rose ME
    Clin Chim Acta; 1992 Oct; 211(1-2):73-81. PubMed ID: 1468155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of very long chain acyl-dehydrogenase deficiency from an infant's newborn screening card.
    Wood JC; Magera MJ; Rinaldo P; Seashore MR; Strauss AW; Friedman A
    Pediatrics; 2001 Jul; 108(1):E19. PubMed ID: 11433098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences between acylcarnitine profiles in plasma and bloodspots.
    de Sain-van der Velden MG; Diekman EF; Jans JJ; van der Ham M; Prinsen BH; Visser G; Verhoeven-Duif NM
    Mol Genet Metab; 2013; 110(1-2):116-21. PubMed ID: 23639448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of supplementation with L-carnitine at a small dose on acylcarnitine profiles in serum and urine and the renal handling of acylcarnitines in a patient with multiple acyl-coenzyme A dehydrogenation defect.
    Yoshino M; Tokunaga Y; Watanabe Y; Yoshida I; Sakaguchi M; Hata I; Shigematsu Y; Kimura M; Yamaguchi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 792(1):73-82. PubMed ID: 12828999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.